Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers

Author(s):

Myron M. Levine, Salim Abdullah, Yaseen M. Arabi, Delese Mimi Darko, Anna P. Durbin, Vicente Estrada, Euzebiusz Jamrozik, Peter G. Kremsner, Rosanna Lagos, Punnee Pitisuttithum, Stanley A. Plotkin, Robert Sauerwein, Sheng Li Shi, Halvor Sommerfelt, Kanta Subbarao, John J. Treanor, Sudhanshu Vrati, Deborah King, Shobana Balasingam, Charlie Weller, Anastazia Older Aguilar, M. Cristina Cassetti, Philip R. Krause, Ana Maria Henao Restrepo

Details:

Clinical Infectious Diseases, Volume 72, Issue 11, 2021-06-01

Article Link: Click here

Affiliations:

• University of Pennsylvania
• Monash University
• Radboud Universiteit
• Universitetet i Bergen
• Johns Hopkins Bloomberg School of Public Health
• Food and Drug Administration
• University of Rochester Medical Center
• Organisation Mondiale de la Santé
• Universitätsklinikum und Medizinische Fakultät Tübingen
• National Institute of Allergy and Infectious Diseases (NIAID)
• Wellcome Trust
• Faculty of Tropical Medicine, Mahidol University
• Department of Microbiology & Immunology
• Universidad Complutense de Madrid, Facultad de Medicina
• Wuhan Institute of Virology Chinese Academy of Sciences
• Bill & Melinda Gates Foundation
• Ifakara Health Institute
• College of Medicine-Riyadh
• Center for Vaccine Development and Global Health (CVD)
• Regional Centre for Biotechnology
• Centre de Recherches Médicales de Lambaréné
• Centro para Vacunas en Desarrollo Chile
• WHO RandD Blueprint COVID-19 Vaccines Working Group